thymine and Glioblastoma studies

Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.

Research Excerpts

Excerpt	Relevance	Reference
"Diallyl disulfide is a redox-sensitive molecule involved in redox cell activities, and thymine is a uracil derivative and one of the well-known bioactive compounds that can enhance the pharmacological activity of doxorubicin."	5.91	Thymine-Modified Nanocarrier for Doxorubicin Delivery in Glioblastoma Cells. ( Amerhanova, SK; Antipin, IS; Bakhtiozina, LR; Kadirov, MK; Lyubina, AP; Mansurova, EE; Nizameev, IR; Semenov, VE; Shulaeva, MM; Voloshina, AD; Ziganshina, AY, 2023)
"Diallyl disulfide is a redox-sensitive molecule involved in redox cell activities, and thymine is a uracil derivative and one of the well-known bioactive compounds that can enhance the pharmacological activity of doxorubicin."	1.91	Thymine-Modified Nanocarrier for Doxorubicin Delivery in Glioblastoma Cells. ( Amerhanova, SK; Antipin, IS; Bakhtiozina, LR; Kadirov, MK; Lyubina, AP; Mansurova, EE; Nizameev, IR; Semenov, VE; Shulaeva, MM; Voloshina, AD; Ziganshina, AY, 2023)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

thymine and Glioblastoma

Research Excerpts

Research

Studies (1)

Authors

Other Studies

Authors	Studies
Ziganshina, AY	1
Mansurova, EE	1
Voloshina, AD	1
Lyubina, AP	1
Amerhanova, SK	1
Shulaeva, MM	1
Nizameev, IR	1
Kadirov, MK	1
Bakhtiozina, LR	1
Semenov, VE	1
Antipin, IS	1